Long-Term Azathioprine for Autoimmune Inflammatory Rheumatic Diseases Increases SCC Risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Increased Incidence of Squamous Cell Carcinoma of the Skin After Long-Term Treatment With Azathioprine in Patients With Auto-Immune Inflammatory Rheumatic Diseases
J Eur Acad Dermatol Venereol 2014 Jan 01;28(1)27-33, JM van den Reek, PP van Lümig, M Janssen, HJ Schers, JC Hendriks, PC van de Kerkhof, MM Seyger, EM de JongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.